BioCanRx

Ottawa, Canada

BioCanRx deals with translation, manufacture and adoption of cancer immunotherapies.

$38.0M raised

Dec 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BioCanRx raised?

BioCanRx has raised $38.0M in total funding. The most recent round was Grant. The last funding was announced in December 2023.

Who are BioCanRx's investors?

BioCanRx's investors include Innovation, Science and Economic Development Canada.

Where is BioCanRx headquartered?

BioCanRx is headquartered in Ottawa, Canada.

What does BioCanRx do?

BioCanRx deals with translation, manufacture and adoption of cancer immunotherapies.

What stage is BioCanRx at?

BioCanRx is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 6, 2023.

MLA

"BioCanRx — Funding & Investors." VCBacked, December 6, 2023, https://www.vcbacked.co/company/biocanrx. Accessed July 2, 2026.

APA

VCBacked. (2023). BioCanRx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/biocanrx

Wikipedia (cite web)

{{cite web |title=BioCanRx — Funding & Investors |url=https://www.vcbacked.co/company/biocanrx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 6, 2023.